Novo Nordisk’s Wegovy and copyright, both equally driven by semaglutide, have revolutionized obesity remedy through unprecedented weight loss benefits.Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd,[three] with production amenities in 9 nations around the world and affiliates or places of work in five